Home / Learn / Resource Detail

Experience with 177Lu Dotatate Therapy for Metastatic Neuroendocrine Cancer at a Quarternary Comprehensive Cancer Center

November 9, 2020

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.